Blood-pressure lowering for the secondary prevention of stroke

Lancet

Volumn 358, Issue 9287, 2001, Pages 1026-1027

  Staessen, Jan A ^a   Wang, Jiguang ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDAPAMIDE; PERINDOPRIL; PLACEBO; THIAZIDE DIURETIC AGENT;

ANAMNESIS; AUTOREGULATION; BLOOD PRESSURE REGULATION; BRAIN ARTERY; BRAIN BLOOD FLOW; BRAIN INFARCTION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL MEDICINE; CLINICAL PRACTICE; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE SEVERITY; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL CARE; NOTE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; STROKE; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

EID: 0035968627     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)06226-2     Document Type: Note

References (10)

1. Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence
2. Blood pressure lowering for the secondary prevention of stroke: Rationale and design for PROGRESS
3. Critical appraisal of the JNC VI, WHO/ISH and BHS guidelines for essential hypertension
4. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI)
5. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension
6. Why are strokes related to hypertension? Classic studies and hypotheses re-visited
7. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
8. Cardiovascular prevention and blood pressure reduction: An overview of the outcome trials
9. Post-stroke antihypertensive treatment study. A preliminary result
10. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial